Pharmathen S.A.
6 products tracked · names used in filings: Pharmathen S.A.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Thorinane enoxaparin sodium | Lapsed | 2016-09-14 |
| 🇪🇺 | Memantine LEK memantine | Withdrawn | 2013-04-21 |
| 🇪🇺 | Sabervel irbesartan | Expired | 2012-04-13 |
| 🇪🇺 | Matever levetiracetam | Authorised | 2011-10-03 |
| 🇪🇺 | Iasibon ibandronic acid | Authorised | 2011-01-21 |
| 🇪🇺 | Grepid clopidogrel | Authorised | 2009-07-27 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.